162
Views
0
CrossRef citations to date
0
Altmetric
Review

Exploring predisposing factors and pathogenesis contributing to injuries of donor lungs

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1191-1203 | Received 19 Jul 2022, Accepted 28 Nov 2022, Published online: 12 Dec 2022

References

  • van der Mark SC, Hoek RAS, Hellemons ME. Developments in lung transplantation over the past decade. Eur Respir Rev. 2020;29(157):190132.
  • Shepherd HM, Gauthier JM, Puri V, et al. Advanced considerations in organ donors. J Thorac Dis. 2021;13(11):6528–6535.
  • Kukreja J, Chen J, Brzezinski M. Redefining marginality: donor lung criteria. Curr Opin Organ Transplant. 2020;25(3):280–284.
  • Wong A, Liu M, Cypel M. Donor management and lung preservation for lung transplantation. Lancet Respir Med. 2013;1(4):318–328.
  • Wong A, Liu M. Inflammatory responses in lungs from donation after brain death: mechanisms and potential therapeutic targets. J Heart Lung Transplant. 2021;40(9):890–896.
  • Cordonnier C, Demchuk A, Ziai W, et al. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018;392(10154):1257–1268.
  • Ehrsam JP, Benden C, Immer FF, et al. Current status and further potential of lung donation after circulatory death. Clin Transplant. 2021;35(7):e14335.
  • Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29(7):749–759.
  • Iskender I, Cypel M, Martinu T, et al. Effects of warm versus cold ischemic donor lung preservation on the underlying mechanisms of injuries during ischemia and reperfusion. Transplantation. 2018;102(5):760–768.
  • Palleschi A, Rosso L, Ruggeri GM, et al. Overcoming the limits of reconditioning: seventeen hours of EVLP with successful transplantation from uncontrolled circulatory death donor. Transplantation. 2021;105(12):2620–2624.
  • Charles EJ, Mehaffey JH, Sharma AK, et al. Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism. J Thorac Cardiovasc Surg. 2017;154(5):1811–1820.
  • Hijiya K, Chen-Yoshikawa TF, Kondo T, et al. Bronchodilator inhalation during ex vivo lung perfusion improves posttransplant graft function after warm ischemia. Ann Thorac Surg. 2017;103(2):447–453.
  • Haam S, Lee S, Paik HC, et al. The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death. Eur J Cardiothorac Surg. 2015;48(4):542–547.
  • Bobba CM, Whitson BA, Henn MC, et al. Trends in donation after circulatory death in lung transplantation in the United States: impact of era. Transpl Int. 2022;35:10172. DOI:10.3389/ti.2022.10172
  • Van Raemdonck D, Keshavjee S, Levvey B, et al. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT registry. J Heart Lung Transplant. 2019;38(12):1235–1245.
  • Zhou J, Chen B, Liao H, et al., The comparable efficacy of lung donation after circulatory death and brain death: a systematic review and meta-analysis. Transplantation. 2019;103(12):2624–2633. .
  • Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22(11):1183–1200.
  • Reyes KG, Mason DP, Thuita L, et al. Guidelines for donor lung selection: time for revision? Ann Thorac Surg. 2010;89(6):1756–1764.
  • Bhorade SM, Vigneswaran W, McCabe MA et al, Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19(12):1199–1204.
  • Halpern SE, Jawitz OK, Raman V, et al., Aggressive pursuit and utilization of non-ideal donor lungs does not compromise post-lung transplant survival. Clin Transplant. 2021;35(9):e14414.
  • Christie IG, Chan EG, Ryan JP, et al. National trends in extended criteria donor utilization and outcomes for lung transplantation. Ann Thorac Surg. 2021;111(2):421–426.
  • Sommer W, Ius F, Müller C, et al. Extended criteria donor lungs do not impact recipient outcomes in pediatric transplantation. J Heart Lung Transplant. 2019;38(5):560–569.
  • Divithotawela C, Cypel M, Martinu T, et al. Long-term outcomes of lung transplant with ex vivo lung perfusion. JAMA Surg. 2019;154(12):1143–1150.
  • Tian D, Wang Y, Shiiya H, et al. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2020;159(2):720–730.
  • Shaver CM, Ware LB. Primary graft dysfunction: pathophysiology to guide new preventive therapies. Expert Rev Respir Med. 2017;11(2):119–128.
  • Šedý J, Kuneš J, Zicha J. Pathogenetic mechanisms of neurogenic pulmonary edema. J Neurotrauma. 2015;32(15):1135–1145.
  • Sanchez PG, Iacono AT, Rajagopal K, et al. Successful lung salvage by ex vivo reconditioning of neurogenic pulmonary edema: case report. Transplant Proc. 2014;46(7):2453–2455.
  • Shivalkar B, Van Loon J, Wieland W, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87(1):230–239.
  • Ranasinghe AM, Bonser RS. Endocrine changes in brain death and transplantation. Best Pract Res Clin Endocrinol Metab. 2011;25(5):799–812.
  • Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020;370:m2177.
  • Sommer W, Kirschner H, Ius F, et al., Transplantation of donor lungs with pulmonary embolism-a retrospective study. Transpl Int. 2019;32(6):658–667.
  • Oto T, Rabinov M, Griffiths AP, et al. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: a major mechanism of primary graft failure? J Thorac Cardiovasc Surg. 2005;130(5):1446.
  • Terada Y, Gauthier JM, Pasque MK, et al. Clinical outcomes of lung transplants from donors with unexpected pulmonary embolism. Ann Thorac Surg. 2021;112(2):387–394.
  • Inci I, Yamada Y, Hillinger S, et al. Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system. Ann Thorac Surg. 2014;98(5):1837–1838.
  • Brown CR, Brozzi NA, Vakil N, et al. Donor lungs with pulmonary embolism evaluated with ex vivo lung perfusion. ASAIO J. 2012;58(4):432–434.
  • Luc JG, Bozso SJ, Freed DH, et al. Successful repair of donation after circulatory death lungs with large pulmonary embolus using the lung organ care system for ex vivo thrombolysis and subsequent clinical transplantation. Transplantation. 2015;99(1):e1–e2.
  • Motoyama H, Chen F, Ohsumi A, et al. Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model. J Heart Lung Transplant. 2013;32(5):505–510.
  • Sutherasan Y, D’Antini D, Pelosi P. Advances in ventilator-associated lung injury: prevention is the target. Expert Rev Respir Med. 2014;8(2):233–248.
  • Roan E, Waters CM. What do we know about mechanical strain in lung alveoli? Am J Physiol Lung Cell Mol Physiol. 2011;301(5):L625–L635.
  • Carteaux G, Parfait M, Combet M, et al. Patient-self inflicted lung injury: a practical review. J Clin Med. 2021;10(12):2738.
  • Gattinoni L, Tonetti T, Cressoni M, et al. Ventilator-related causes of lung injury: the mechanical power. Intensive Care Med. 2016;42(10):1567–1575.
  • Sugimoto S, Kurosaki T, Otani S, et al. Feasibility of lung transplantation from donors mechanically ventilated for prolonged periods. Surg Today. 2019;49(3):254–260.
  • Monjezi M, Jamaati H, Noorbakhsh F. Attenuation of ventilator-induced lung injury through suppressing the pro-inflammatory signaling pathways: a review on preclinical studies. Mol Immunol. 2021;135:127–136.
  • Kuipers MT, van der Poll T, Schultz MJ, et al. Bench-to-bedside review: damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care. 2011;15(6):235.
  • Dias-Freitas F, Metelo-Coimbra C, Roncon-Albuquerque R Jr. Molecular mechanisms underlying hyperoxia acute lung injury. Respir Med. 2016;119:23–28.
  • Rendeki S, Molnár TF. Pulmonary contusion. J Thorac Dis. 2019;11(Suppl 2):S141–S151.
  • Tran A, Fernando SM, Brochard LJ, et al. Prognostic factors for development of acute respiratory distress syndrome following traumatic injury: a systematic review and meta-analysis. Eur Respir J. 2022;59(4):2100857.
  • Wang S, Ruan Z, Zhang J, et al. The value of pulmonary contusion volume measurement with three-dimensional computed tomography in predicting acute respiratory distress syndrome development. Ann Thorac Surg. 2011;92(6):1977–1983.
  • Schwarz S, Rahimi N, Kifjak D, et al., Lungs from polytrauma donors with significant chest trauma can be safely used for transplantation. J Thorac Cardiovasc Surg. 2022;163(5):1719–1731. .
  • Spies C, Trohman RG. Narrative review: electrocution and life-threatening electrical injuries. Ann Intern Med. 2006;145(7):531–537.
  • Kanchan T, Meshram VP, Shekhawat RS, et al. Electricity induced burns and lung injury: a rare autopsy observation. J Burn Care Res. 2021;42(5):1050–1052.
  • Zhou HM, Xu SJ, Wang L, et al. Influences of high-voltage electrical burns on the pulmonary microcirculation in rabbits. Clin Hemorheol Microcirc. 2016;62(3):193–203.
  • Blumenthal R, Saayman G. Bone marrow embolism to the lung in electrocution: two case reports. Am J Forensic Med Pathol. 2014;35(3):170–171.
  • Baral P, Batra S, Zemans RL, et al. Divergent functions of Toll-like receptors during bacterial lung infections. Am J Respir Crit Care Med. 2014;190(7):722–732.
  • Liu S, Su X, Pan P, et al. Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury. Sci Rep. 2016;6(1):37252.
  • Ahmad O, Shafii AE, Mannino DM, et al. Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post-transplant period. Transpl Infect Dis. 2018;20(6):e12986.
  • Avlonitis VS, Krause A, Luzzi L, et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg. 2003;24(4):601–607.
  • Fishman JA, Grossi PA. Donor-derived infection–the challenge for transplant safety. Nat Rev Nephrol. 2014;10(11):663–672.
  • Nakajima D, Cypel M, Bonato R, et al. Ex vivo perfusion treatment of infection in human donor lungs. Am J Transplant. 2016;16(4):1229–1237.
  • Yoo JK, Kim TS, Hufford MM, et al. Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol. 2013;132(6):1263–1276.
  • Ribeiro RVP, Ku T, Wang A, et al. Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin. J Heart Lung Transplant. 2022;41(3):287–297.
  • Bridges ND, Spray TL, Collins MH, et al. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg. 1998;116(4):617–623.
  • Englum BR, Ganapathi AM, Speicher PJ, et al. Impact of donor and recipient hepatitis C status in lung transplantation. J Heart Lung Transplant. 2016;35(2):228–235.
  • Cypel M, Feld JJ, Galasso M, et al. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial. Lancet Respir Med. 2020;8(2):192–201.
  • Belga S, Kabbani D, Doucette K. Hepatitis B surface antigen-positive donor to negative recipient lung transplantation. Am J Transplant. 2020;20(8):2287–2288.
  • Eichenberger EM, Vece GR, Kakoullis S, et al. Viremic hepatitis B donors: a case of why it’s time to further expand the donor pool for thoracic transplant. J Heart Lung Transplant. 2020;39(4):S20.
  • Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015;15(5):1162–1172.
  • Russo FP, Viganò M, Stock P, et al. HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist. J Hepatol. 2022;77(2):503–515.
  • Cribbs SK, Crothers K, Morris A. Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation. Physiol Rev. 2020;100(2):603–632.
  • Upadhya S, Rehman J, Malik AB, et al. Mechanisms of lung injury induced by SARS-CoV-2 infection. Physiology (Bethesda). 2022;37(2):88–100.
  • Ceulemans LJ, Van Slambrouck J, De Leyn P, et al. Successful double-lung transplantation from a donor previously infected with SARS-CoV-2. Lancet Respir Med. 2021;9(3):315–318.
  • Kim HJ, Shin DH, Cho WH, et al. Successful lung transplantation from a donor who had recovered from severe acute respiratory syndrome coronavirus 2 pneumonia. Ann Thorac Surg. 2022;113(5):e351–e354.
  • Kaul DR, Valesano AL, Petrie JG, et al. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing. Am J Transplant. 2021;21(8):2885–2889.
  • Van Slambrouck J, Van Raemdonck D, Wauters J, et al. Lung donation and SARS-CoV-2 transmission: missed detection versus missed opportunity? Immun Inflamm Dis. 2022;10(4):e603.
  • Raghavendran K, Nemzek J, Napolitano LM, et al. Aspiration-induced lung injury. Crit Care Med. 2011;39(4):818–826.
  • Nakajima D, Liu M, Ohsumi A, et al. Lung lavage and surfactant replacement during ex vivo lung perfusion for treatment of gastric acid aspiration-induced donor lung injury. J Heart Lung Transplant. 2017;36(5):577–585.
  • Thom O, Roberts K, Devine S, et al. Treatment of the lung injury of drowning: a systematic review. Crit Care. 2021;25(1):253.
  • Pasupneti S, Patel K, Mooney JJ, et al., Lung transplantation following death by drowning: a review of the current literature. Clin Transplant. 2016;30(10):1195–1197.
  • Tsou S, Chen J, Brzezinski M, et al., Lung transplantation from swimming pool drowning victims: a case series. Am J Transplant. 2021;21(6):2273–2278. .
  • McNamee CJ, Modry DL, Lien D, et al. Drowned donor lung for bilateral lung transplantation. J Thorac Cardiovasc Surg. 2003;126(3):910–912.
  • Whitson BA, Hertz MI, Kelly RF, et al. Use of the donor lung after asphyxiation or drowning: effect on lung transplant recipients. Ann Thorac Surg. 2014;98(4):1145–1151.
  • Seese L, Kilic A, Turbendian HK, et al. The impact of donor asphyxiation or drowning on pediatric lung transplant recipients. Transplantation. 2021;105(3):620–627.
  • Guo B, Bai Y, Ma Y, et al. Preclinical and clinical studies of smoke-inhalation-induced acute lung injury: update on both pathogenesis and innovative therapy. Ther Adv Respir Dis. 2019;13:1753466619847901.
  • Moolji J, Gill I, Varughese R, et al. Successful long-term outcome after transplantation of lungs affected by smoke inhalation injury. Ann Thorac Surg. 2022;114(1):25–28.
  • Lautner LJ, Freed DH, Nagendran J, et al. Current techniques and the future of lung preservation. Cryobiology. 2020;94:1–8.
  • Chatterjee S, Nieman GF, Christie JD, et al. Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation. Am J Physiol Lung Cell Mol Physiol. 2014;307(9):L668–L680.
  • Noda K, Philips BJ, Snyder ME, et al. Heparanase inhibition preserves the endothelial glycocalyx in lung grafts and improves lung preservation and transplant outcomes. Sci Rep. 2021;11(1):12265.
  • Ali A, Wang A, Ribeiro RVP, et al. Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function. Sci Transl Med. 2021;13(611):eabf7601.
  • Saeb-Parsy K, Martin JL, Summers DM, et al. Mitochondria as therapeutic targets in transplantation. Trends Mol Med. 2021;27(2):185–198.
  • Hashimoto K, Cypel M, Juvet S, et al. Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation. J Heart Lung Transplant. 2017;S1053-2498(17):31870–31873.
  • Kanou T, Nakahira K, Choi AM, et al. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation. J Thorac Cardiovasc Surg. 2021;162(2):490–499.
  • Hernández-Jiménez C, Olmos-Zúñiga JR, Baltazares-Lipp M, et al. Endothelin-converting enzyme 1 and vascular endothelial growth factor as potential biomarkers during ex vivo lung perfusion with prolonged hypothermic lung-sparing. Dis Markers. 2022;2022:6412238.
  • Caldarone L, Mariscal A, Sage A, et al. Neutrophil extracellular traps in ex vivo lung perfusion perfusate predict the clinical outcome of lung transplant recipients. Eur Respir J. 2019;53(4):1801736.
  • Cypel M, Keshavjee S. The clinical potential of ex vivo lung perfusion. Expert Rev Respir Med. 2012;6(1):27–35.
  • Iske J, Hinze CA, Salman J, et al. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury. Am J Transplant. 2021;21(12):3831–3839.
  • Lightle W, Daoud D, Loor G. Breathing lung transplantation with the Organ Care System (OCS) Lung: lessons learned and future implications. J Thorac Dis. 2019;11(Suppl 14):S1755–S1760.
  • Warnecke G, Van Raemdonck D, Smith MA, et al., Normothermic ex-vivo preservation with the portable organ care system lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. Lancet Respir Med. 2018;6(5):357–367.
  • Valenza F, Rosso L, Pizzocri M, et al. The consumption of glucose during ex vivo lung perfusion correlates with lung edema. Transplant Proc. 2011;43(4):993–996.
  • Mazzeo AT, Fanelli V, Boffini M, et al. Feasibility of lung microdialysis to assess metabolism during clinical ex vivo lung perfusion. J Heart Lung Transplant. 2019;38(3):267–276.
  • Harada M, Oto T, Otani S, et al. A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion. Gen Thorac Cardiovasc Surg. 2015;63(12):645–651.
  • Lin H, Chen M, Tian F, et al. α1-Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion. J Heart Lung Transplant. 2018;37(5):656–666.
  • Burki S, Noda K, Philips BJ, et al. Impact of triptolide during ex vivo lung perfusion on grafts after transplantation in a rat model. J Thorac Cardiovasc Surg. 2020;S0022-5223(20):30191–30194.
  • Buchko MT, Stewart CJ, Hatami S, et al. Total parenteral nutrition in ex vivo lung perfusion: addressing metabolism improves both inflammation and oxygenation. Am J Transplant. 2019;19(12):3390–3397.
  • Arni S, Necati C, Maeyashiki T, et al. Perfluorocarbon-based oxygen carriers and subnormothermic lung machine perfusion decrease production of pro-inflammatory mediators. Cells. 2021;10(9):2249.
  • Michaelsen VS, Ribeiro RVP, Ali A, et al. Safety of continuous 12-hour delivery of antimicrobial doses of inhaled nitric oxide during ex vivo lung perfusion. J Thorac Cardiovasc Surg. 2022;163(3):841–849.
  • Kondo T, Chen F, Ohsumi A, et al. β2-adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung Injury. Ann Thorac Surg. 2015;100(2):480–486.
  • De Wolf J, Glorion M, Jouneau L, et al. Challenging the ex vivo lung perfusion procedure with continuous dialysis in a pig model. Transplantation. 2022;106(5):979–987.
  • O’Neill JD, Guenthart BA, Hozain AE, et al. Xenogeneic support for the recovery of human donor organs. J Thorac Cardiovasc Surg. 2022;163(4):1563–1570.
  • Tanaka Y, Noda K, Isse K, et al. A novel dual ex vivo lung perfusion technique improves immediate outcomes in an experimental model of lung transplantation. Am J Transplant. 2015;15(5):1219–1230.
  • Aboelnazar NS, Himmat S, Hatami S, et al. Negative pressure ventilation decreases inflammation and lung edema during normothermic ex-vivo lung perfusion. J Heart Lung Transplant. 2018;37(4):520–530.
  • Buchko MT, Boroumand N, Cheng JC, et al., Clinical transplantation using negative pressure ventilation ex situ lung perfusion with extended criteria donor lungs. Nat Commun. 2020;11(1):5765.
  • Ordies S, Frick AE, Claes S, et al. Prone positioning during ex vivo lung perfusion influences regional edema accumulation. J Surg Res. 2019;239:300–308.
  • Ayyat KS, Okamoto T, Niikawa H, et al. High positive end-expiratory pressure during ex vivo lung perfusion: recruiting rejected donor lungs. Interact Cardiovasc Thorac Surg. 2018;27(1):145–147.
  • Mehaffey JH, Charles EJ, Sharma AK, et al. Airway pressure release ventilation during ex vivo lung perfusion attenuates injury. J Thorac Cardiovasc Surg. 2017;153(1):197–204.
  • Courtwright A, Cantu E. Evaluation and management of the potential lung donor. Clin Chest Med. 2017;38(4):751–759.
  • DeCampos KN, Keshavjee S, Liu M, et al. Optimal inflation volume for hypothermic preservation of rat lungs. J Heart Lung Transplant. 1998;17(6):599–607.
  • Patel MR, Laubach VE, Tribble CG, et al. Hyperinflation during lung preservation and increased reperfusion injury. J Surg Res. 2005;123(1):134–138.
  • Hu X, Cowl CT, Baqir M, et al. Air travel and pneumothorax. Chest. 2014;145(4):688–694.
  • Holthof K, Bridevaux PO, Frésard I. Underlying lung disease and exposure to terrestrial moderate and high altitude: personalised risk assessment. BMC Pulm Med. 2022;22(1):187.
  • Bellinghausen AL, Mandel J. Assessing patients for air travel. Chest. 2021;159(5):1961–1967.
  • Loor G, Huddleston S, Hartwig M, et al. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg. 2022;164(5):1351–1361.
  • Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013;187(5):527–534.
  • Millar JE, Fanning JP, McDonald CI, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20(1):387.
  • Minqiang L, Xiaoshan L, Bo X, et al. A retrospective analysis for risk factors and early prognosis of delayed withdrawal extracorporeal membrane oxygenation after lung transplantation. Transplantation. 2021;105(4):867–875.
  • McVey MJ, Kapur R, Cserti-Gazdewich C, et al. Transfusion-related acute lung injury in the perioperative patient. Anesthesiology. 2019;131(3):693–715.
  • Geube MA, Perez-Protto SE, McGrath TL, et al. Increased intraoperative fluid administration is associated with severe primary graft dysfunction after lung transplantation. Anesth Analg. 2016;122(4):1081–1088.
  • Atchade E, Elmaleh Y, Zappella N, et al. Massive intraoperative red blood cell transfusion during lung transplantation is strongly associated with 90-day mortality. Anaesth Crit Care Pain Med. 2022;41(5):101118.
  • Frye CC, Bery AI, Kreisel D, et al. Sterile inflammation in thoracic transplantation. Cell Mol Life Sci. 2021;78(2):581–601.
  • Capuzzimati M, Hough O, Liu M. Cell death and ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant. 2022;S1053-2498(22):01954.
  • Bauer TM, Murphy E. Role of mitochondrial calcium and the permeability transition pore in regulating cell death. Circ Res. 2020;126(2):280–293.
  • Kotloff RM, Blosser S, Fulda GJ, et al., Management of the potential organ donor in the ICU: society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015;43(6):1291–1325.
  • Soluri-Martins A, Sutherasan Y, Silva PL, et al. How to minimise ventilator-induced lung injury in transplanted lungs: the role of protective ventilation and other strategies. Eur J Anaesthesiol. 2015;32(12):828–836.
  • Chiu S, Mills SEA, Bharat A. Expanding the lung donor pool and improving outcomes: ex vivo lung perfusion. JAMA Surg. 2019;154(12):1151.
  • Abdoul N, Legeai C, Cantrelle C, et al. Impact of ex vivo lung perfusion on brain-dead donor lung utilization: the French experience. Am J Transplant. 2022;22(5):1409–1417.
  • Valenza F, Rosso L, Coppola S, et al. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation. Transpl Int. 2014;27(6):553–661.
  • Machuca TN, Cypel M, Bonato R, et al. Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model. Hum Gene Ther. 2017;28(9):757–765.
  • Nakajima D, Watanabe Y, Ohsumi A, et al. Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant. 2019;38(11):1214–1223.
  • den Hengst WA, Gielis JF, Lin JY, et al. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299(5):H1283–H1299.
  • Chen F, Date H. Update on ischemia-reperfusion injury in lung transplantation. Curr Opin Organ Transplant. 2015;20(5):515–520.
  • Wang Y, Dong Z, Zhang Z, et al. Postconditioning with Irisin attenuates lung ischemia/reperfusion injury by suppressing ferroptosis via induction of the Nrf2/HO-1 signal axis. Oxid Med Cell Longev. 2022;2022:9911167.
  • Wu S, Li Z, Ye M, et al. VX765, a specific caspase-1 inhibitor, alleviates lung ischemia reperfusion injury by suppressing endothelial pyroptosis and barrier dysfunction. Biomed Res Int. 2021;2021:4525988.
  • Nakata K, Okazaki M, Shimizu D, et al. Protective effects of anti-HMGB1 monoclonal antibody on lung ischemia reperfusion injury in mice. Biochem Biophys Res Commun. 2021;573:164–170.
  • Jiang T, Liu T, Deng X, et al. Adiponectin ameliorates lung ischemia-reperfusion injury through SIRT1-PINK1 signaling-mediated mitophagy in type 2 diabetic rats. Respir Res. 2021;22(1):258.
  • Oda H, Tanaka S, Shinohara M, et al. Specialized proresolving lipid meditators agonistic to formyl peptide receptor type 2 attenuate ischemia-reperfusion injury in rat lung. Transplantation. 2022;106(6):1159–1169.
  • Harano T, Ryan JP, Morrell MR, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation. ASAIO J. 2021;67(9):1071–1078.
  • Wigfield CH, Lindsey JD, Steffens TG, et al. Early institution of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation improves outcome. J Heart Lung Transplant. 2007;26(4):331–338.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.